The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Clinical Pharmacology of MAO Inhibitors: Safety and Future
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular biology of the human CYP2C subfamily
Goldstein, J. A., & de Morais, S. M. F. (1994) · Pharmacogenetics · doi:10.1097/00008571-199412000-00001 · Cited by 529
Biochemical changes in Dementia disorders of Alzheimer type (AD/SDAT)
Gottfries, C.-G., Adolfsson, R., Aquilonius, S.-M., Carlsson, A., Eckernas, S.-A., Nordberg, A., Oreland, L., Svennerholm, L., Wiberg, Å., & Winblad, B. (1983) · Neurobiology of Aging · doi:10.1016/0197-4580(83)90002-7 · Cited by 304
Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors???
Baumann, P. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631060-00004 · Cited by 212
Monoamine oxidase-B inhibitors in the treatment of Alzheimers disease
Thomas, T. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00100-7 · Cited by 201
Inaba, T., Jurima, M., Mahon, W. A., & Kalow, W. (1985) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08231-5 · Cited by 179
The new generation of monoamine oxidase inhibitors
Cesura, A. M., & Pletscher, A. (1992) · Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques · doi:10.1007/978-3-0348-7141-9_3 · Cited by 167
Shoulson, I. (1998) · PubMed · Cited by 154
Volz, H., & Gleiter, C. H. (1998) · Drugs & Aging · doi:10.2165/00002512-199813050-00002 · Cited by 110
Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study*
Gram, L. F., Guentert, T. W., Grange, S., Vistisen, K. K., & Brøsen, K. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90230-9 · Cited by 100
Neurobiology and Clinical Pharmacology of Obsessive-Compulsive Disorder
Micallef, J., & Blin, O. (2001) · Clinical Neuropharmacology · doi:10.1097/00002826-200107000-00002 · Cited by 96
Cited by
Binda, C., Wang, J., Pisani, L., Caccia, C., Carotti, A., Salvati, P., Edmondson, D. E., & Mattevi, A. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070677y · Cited by 607
Osório, F. D. L., Sanches, R. F., Macedo, L. R., dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2015) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2014-1496 · Cited by 488
β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)
Herraiz, T., González, D., Ancín-Azpilicueta, C., Arán, V. J., & Guillén, H. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.12.019 · Cited by 357
Jäger, A. K., & Saaby, L. (2011) · Molecules · doi:10.3390/molecules16021471 · Cited by 330
Risks of combined alcohol/medication use in older adults
Moore, A. A., Whiteman, E. J., & Ward, K. T. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.03.006 · Cited by 307
Metadata
- Authors
- Yamada, M.
- Venue
- NeuroToxicology
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 25
- Issue
- 1-2
- Pages
- 215-221
- ISSN
- 0161-813X (ISSN-L)
- OpenAlex
- W2079154850
- Cited by
- 324
- References
- 30
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Pharmacology of MAO Inhibitors: Safety and Future. https://app.cochat.ai/papers/10.1016/s0161-813x(03)00097-4
- The paper
- Yamada, M. (2004). Clinical Pharmacology of MAO Inhibitors: Safety and Future. NeuroToxicology. https://doi.org/10.1016/s0161-813x(03)00097-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
